CLNN
Clene Inc.
NASDAQ · USHealthcareBiotechnology
$5.73-3.21%
Price as of Jul 20, 2026
CLNN capital
Clene Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -1.17x
- Net debt / equity
- -0.86x
- Debt / assets
- 1.02x
- Debt / EBITDA
- -0.76x
- Net debt / EBITDA
- -0.55x
Liquidity & coverage
- Current ratio
- 1.94x
- Quick ratio
- 1.93x
- Cash ratio
- 0.88x
- Interest coverage
- -7.27x
- EBITDA / interest
- -10.19x
- Working capital
- $6.3M
Cash & dividend
- FCF / debt
- -0.82x
- Cash flow / debt
- -0.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.